Market Tracker

10/20 3:58am ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

16.32
Data as of Oct 17
 -1.03 / -5.94%
Today’s Change
8.57
Today|||52-Week Range
20.29
+74.73%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close17.35
Today’s open17.57
Day’s range-- - --
Volume824,914
Average volume (3 months)530,949
Market cap$1.2B
Dividend yield--
Data as of 10/17/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-13.53%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book9.13

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+0.59+5.32%
GWPHGW Pharmaceuticals P...+0.37+0.59%
PTCTPTC Therapeutics Inc-0.52-1.38%
CMRXChimerix Inc-1.25-3.53%
Data as of 3:59pm ET, 10/17/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts